Form 8-K - Current report:
SEC Accession No. 0001104659-21-143341
Filing Date
2021-11-24
Accepted
2021-11-24 09:21:12
Documents
14
Period of Report
2021-11-24
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2133709d3_8k.htm   iXBRL 8-K 39345
2 EXHIBIT 99.1 tm2133709d3_ex99-1.htm EX-99.1 17960
6 GRAPHIC tm2133709d3_ex99-1img001.jpg GRAPHIC 6304
  Complete submission text file 0001104659-21-143341.txt   247302

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA supn-20211124.xsd EX-101.SCH 3025
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE supn-20211124_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE supn-20211124_pre.xml EX-101.PRE 22359
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2133709d3_8k_htm.xml XML 3493
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35518 | Film No.: 211441432
SIC: 2834 Pharmaceutical Preparations